SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients

Area of Science:

• Immunology
• Transplant Medicine
• Infectious Diseases

Background:

• The COVID-19 pandemic presents unique challenges for solid organ transplant (SOT) recipients.
• High mortality rates persist in SOT patients despite available treatments and SARS-CoV-2 vaccination.
• Vaccine immunogenicity and efficacy are reduced in SOT recipients compared to the general population.

Purpose of the Study:

• To provide an update on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination strategies for SOT recipients.
• To review essential preventive measures for SOT patients during the COVID-19 pandemic.
• To discuss the current literature and international guidelines regarding vaccination in this vulnerable group.

Main Methods:

• Literature review of existing studies on COVID-19 vaccination in SOT recipients.
• Analysis of international guidelines and recommendations.
• Synthesis of data on vaccine immunogenicity, efficacy, and safety in SOT patients.

Main Results:

• Priority vaccination is recommended for SOT candidates and recipients due to reduced COVID-19 complication risks.
• Lower immunogenicity and efficacy of vaccines are observed in SOT recipients.
• Continued adherence to protective measures and consideration of passive antibody prophylaxis are advised post-vaccination.

Conclusions:

• SOT recipients remain at high risk for severe COVID-19 outcomes.
• Despite vaccination, SOT patients must maintain protective measures.
• Further research on assessing immune responses post-vaccination is crucial for optimizing protection.